Literature DB >> 26819093

Atypical Leber Hereditary Optic Neuropathy: 18 Year Interval Between Eyes.

Kaitlyn L Ohden1, Peter H Tang, Chrystia C Lilley, Michael S Lee.   

Abstract

A 5-year-old boy developed profound loss of vision in his right eye and was found to have a 11778 mitochondrial point mutation consistent with Leber hereditary optic neuropathy (LHON). He maintained 20/20 vision in the left eye for 18 years until age 23, when he experienced loss of vision in that eye. This 18 year interval between eye involvement in LHON is the longest reported to date and reinforces the variability in presentation and progression seen in this disease.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26819093     DOI: 10.1097/WNO.0000000000000346

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  4 in total

1.  Leber Hereditary Optic Neuropathy with Interval of Visual Loss Greater Than 12 Months.

Authors:  Renata Cristina Ferreira Prado; Frederico Castelo Moura
Journal:  Neuroophthalmology       Date:  2016-09-01

2.  Gene Therapy for Leber Hereditary Optic Neuropathy: Low- and Medium-Dose Visual Results.

Authors:  John Guy; William J Feuer; Janet L Davis; Vittorio Porciatti; Phillip J Gonzalez; Rajeshwari D Koilkonda; Huijun Yuan; William W Hauswirth; Byron L Lam
Journal:  Ophthalmology       Date:  2017-06-21       Impact factor: 12.079

3.  Cyclosporine A does not prevent second-eye involvement in Leber's hereditary optic neuropathy.

Authors:  Stéphanie Leruez; Christophe Verny; Dominique Bonneau; Vincent Procaccio; Guy Lenaers; Patrizia Amati-Bonneau; Pascal Reynier; Clarisse Scherer; Adriana Prundean; Christophe Orssaud; Xavier Zanlonghi; Marie-Bénédicte Rougier; Caroline Tilikete; Dan Miléa
Journal:  Orphanet J Rare Dis       Date:  2018-02-17       Impact factor: 4.123

4.  Atypical Leber hereditary optic neuropathy with a 34-year interval between vision loss in both eyes.

Authors:  Kayo Sugiura; Shimpei Ishimaru; Ken Fukuda
Journal:  Am J Ophthalmol Case Rep       Date:  2022-01-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.